PEspeaks

Jul 07, 2017
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Three messages that resonated from this year’s annual meeting of the Drug Information Association.
Jul 07, 2017
Pharmaceutical Executive
As we step further into the waters of value-based contracting arrangements, lessons learned must be shared—including the role of the patient in the equation.
Jul 06, 2017
The FDA ruling that exempts biosimilar makers from waiting an extra six months after approval to distribute a new product should help overcome delays in future biosimilar sales, writes Jill Wechsler.
Jun 26, 2017
Intellectual property analysis of one recently approved drug shows how Valeant might have missed out on at least one vital acquisition opportunity. Duncan Clark reports.
Jun 26, 2017
Pharmaceutical Executive
Outlining the new leadership and C-level roles of tomorrow needed to take on the disruption event on pharma's horizon.
Jun 19, 2017
Pharmaceutical Executive
Last month’s EFPIA and EU Health Council annual conferences highlighted the growing divisions—and resentments—between industry and governments on drug pricing. Reflector reports.
Jun 16, 2017
Congressional measures lack the support to move forward, writes Jill Wechsler.
Jun 11, 2017
No one thought Brexit would be easy and in the wake of last week's UK election the going has only gotten tougher. Leela Barham looks at the fallout from a life sciences perspective.
Jun 09, 2017
Pharmaceutical Executive
There's no shortage of talent, expertise and passion in the biopharma industry. It's time for that talent to shine, writes Lisa Henderson.
Jun 07, 2017
Pharmaceutical Executive
Average total compensation, base salary for medical sales reps rise, according to study.
native1_300x100
lorem ipsum